Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-05-07 Sale | 2025-05-09 9:30 pm | OS Therapies Inc | OSTX | Auerbach Shalom Einodmil LLC 10% Owner | 82,000 | $1.999 | $163,918 | 2,687,570 (Indirect Direct) | View |
| 2025-04-09 Sale | 2025-04-11 9:45 pm | OS Therapies Inc | OSTX | Auerbach Shalom Einodmil LLC 10% Owner | 60,012 | $1.3592 | $81,566 | 2,769,570 (Indirect Direct) | View |
| 2025-02-14 Sale | 2025-02-18 9:00 pm | OS Therapies Inc | OSTX | Auerbach Shalom Einodmil LLC 10% Owner | 100,000 | $2.843 | $284,300 | 2,454,582 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-11-10 Option Award | 2026-11-12 4:30 pm | N/A 2036-11-10 | OS Therapies Inc | OSTX | Clem Kerry M Chief Commercial Officer | 900,000 | $0 | 925,000 (Direct) | View |
| 2026-11-10 Option Award | 2026-11-12 4:30 pm | N/A 2036-11-10 | OS Therapies Inc | OSTX | Francis Knuettel II Chief Financial Officer | 1,000,000 | $0 | 1,020,000 (Direct) | View |
| 2026-10-22 Option Award | 2026-10-30 9:00 pm | N/A 2036-10-22 | OS Therapies Inc | OSTX | PETIT ROBERT See Remarks | 200,000 | $0 | 400,000 (Direct) | View |
| 2026-10-22 Option Award | 2026-10-30 8:59 pm | N/A 2036-10-22 | OS Therapies Inc | OSTX | McKean-Dieser Avril Suzette Director | 300,000 | $0 | 305,000 (Direct) | View |
| 2026-10-22 Option Award | 2026-10-30 8:59 pm | N/A 2036-10-22 | OS Therapies Inc | OSTX | Romness Paul A. President and CEO | 900,000 | $0 | 3,373,000 (Direct) | View |
| 2026-10-22 Option Award | 2026-10-30 8:59 pm | N/A 2036-10-22 | OS Therapies Inc | OSTX | Search Theodore F. Director | 300,000 | $0 | 755,835 (Direct) | View |
| 2026-10-22 Option Award | 2026-10-30 8:59 pm | N/A 2036-10-22 | OS Therapies Inc | OSTX | Ciccio John Director | 300,000 | $0 | 755,835 (Direct) | View |
| 2026-10-22 Option Award | 2026-10-30 8:58 pm | N/A 2036-10-22 | OS Therapies Inc | OSTX | Jarry Olivier Roger Director | 300,000 | $0 | 300,000 (Direct) | View |
| 2026-10-22 Option Award | 2026-10-30 8:58 pm | N/A 2036-10-22 | OS Therapies Inc | OSTX | EAGLE CRAIG Director | 300,000 | $0 | 300,000 (Direct) | View |
| 2026-10-22 Option Award | 2026-10-30 8:58 pm | N/A 2036-10-22 | OS Therapies Inc | OSTX | Francis Knuettel II Chief Financial Officer | 300,000 | $0 | 320,000 (Direct) | View |
| 2026-10-22 Option Award | 2026-10-30 8:57 pm | N/A 2036-10-22 | OS Therapies Inc | OSTX | Clem Kerry M Chief Commercial Officer | 300,000 | $0 | 325,000 (Direct) | View |
Ownership | 2026-10-05 4:49 pm | N/A N/A | OS Therapies Inc | OSTX | Clem Kerry M Chief Commercial Officer | 0 | $0 | 55,000 (Direct) | View |
Ownership | 2026-10-05 4:48 pm | N/A N/A | OS Therapies Inc | OSTX | Francis Knuettel II Chief Financial Officer | 0 | $0 | 20,000 (Indirect) | View |
| 2024-12-05 Ownership(A) | 2026-05-15 6:30 pm | N/A N/A | OS Therapies Inc | OSTX | Romness Paul A. President and CEO | 500,000 | $0 | 2,748,000 (Direct) | View |
Ownership(A) | 2026-05-15 6:30 pm | N/A N/A | OS Therapies Inc | OSTX | Romness Paul A. President and CEO | 0 | $0 | 2,748,000 (Direct) | View |
| 2026-01-22 Option Award | 2026-02-13 4:43 pm | N/A 2036-01-22 | OS Therapies Inc | OSTX | McKean-Dieser Avril Suzette Director | 50,000 | $0 | 55,000 (Direct) | View |
| 2026-01-22 Option Award | 2026-02-13 4:43 pm | N/A 2036-01-22 | OS Therapies Inc | OSTX | Search Theodore F. Director | 50,000 | $0 | 505,835 (Direct) | View |
| 2026-01-22 Option Award | 2026-02-13 4:42 pm | N/A 2036-01-22 | OS Therapies Inc | OSTX | Ciccio John Director | 50,000 | $0 | 505,835 (Direct) | View |
| 2026-01-22 Option Award | 2026-02-13 4:42 pm | N/A 2036-01-22 | OS Therapies Inc | OSTX | Acevedo Christopher P. Chief Financial Officer | 100,000 | $0 | 209,375 (Direct) | View |
| 2026-01-22 Option Award | 2026-02-13 4:41 pm | N/A 2036-01-22 | OS Therapies Inc | OSTX | PETIT ROBERT See Remarks | 100,000 | $0 | 300,000 (Direct) | View |
| 2026-01-22 Option Award | 2026-02-13 4:41 pm | N/A 2036-01-22 | OS Therapies Inc | OSTX | Romness Paul A. President and CEO | 1,000,000 | $0 | 3,473,000 (Direct) | View |
| 2026-01-22 Option Award | 2026-02-13 4:41 pm | N/A 2036-01-22 | OS Therapies Inc | OSTX | Jarry Olivier Roger Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2026-01-22 Option Award | 2026-02-13 4:40 pm | N/A 2036-01-22 | OS Therapies Inc | OSTX | Galzahr Karim Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2025-10-21 Option Award(A) | 2026-02-13 4:20 pm | N/A 2035-10-21 | OS Therapies Inc | OSTX | Romness Paul A. President and CEO | 1,000,000 | $0 | 3,473,000 (Direct) | View |
| 2025-10-21 Option Award | 2025-12-19 6:31 pm | N/A 2035-10-21 | OS Therapies Inc | OSTX | Search Theodore F. Director | 140,000 | $0 | 595,835 (Direct) | View |
| 2025-10-21 Option Award | 2025-12-19 6:31 pm | N/A 2035-10-21 | OS Therapies Inc | OSTX | PETIT ROBERT See Remarks | 500,000 | $0 | 700,000 (Direct) | View |
| 2025-10-21 Option Award | 2025-12-19 6:31 pm | N/A 2035-10-21 | OS Therapies Inc | OSTX | Romness Paul A. President and CEO | 1,950,000 | $0 | 4,423,000 (Direct) | View |
| 2025-10-21 Option Award | 2025-12-19 6:31 pm | N/A 2035-10-21 | OS Therapies Inc | OSTX | Jarry Olivier Roger Director | 140,000 | $0 | 140,000 (Direct) | View |
| 2025-10-21 Option Award | 2025-12-19 6:30 pm | N/A 2035-10-21 | OS Therapies Inc | OSTX | Galzahr Karim Director | 140,000 | $0 | 140,000 (Direct) | View |
| 2025-10-21 Option Award | 2025-12-19 6:30 pm | N/A 2035-10-21 | OS Therapies Inc | OSTX | Ciccio John Director | 140,000 | $0 | 595,835 (Direct) | View |
| 2025-10-21 Option Award | 2025-12-19 6:30 pm | N/A 2035-10-21 | OS Therapies Inc | OSTX | Acevedo Christopher P. Chief Financial Officer | 200,000 | $0 | 309,375 (Direct) | View |
| 2025-10-21 Option Award | 2025-12-19 6:30 pm | N/A 2035-10-21 | OS Therapies Inc | OSTX | McKean-Dieser Avril Suzette Director | 140,000 | $0 | 145,000 (Direct) | View |
| 2025-02-28 Other | 2025-02-28 6:03 pm | N/A N/A | OS Therapies Inc | OSTX | Romness Paul A. President and CEO 10% Owner | 225,000 | $0 | 2,698,000 (Direct) | View |
| 2025-02-27 Other | 2025-02-28 4:05 pm | N/A N/A | OS Therapies Inc | OSTX | Auerbach Shalom Einodmil LLC 10% Owner | 225,000 | $1.64 | 3,054,582 (Indirect) | View |
Ownership(A) | 2025-02-26 4:30 pm | N/A N/A | OS Therapies Inc | OSTX | Auerbach Shalom Einodmil LLC 10% Owner | 0 | $0 | 4,699,375 (Indirect) | View |
| 2024-12-05 Ownership | 2025-02-14 4:26 pm | N/A N/A | OS Therapies Inc | OSTX | Search Theodore F. Director | 40,000 | $0 | 495,835 (Direct) | View |
Ownership | 2025-02-14 4:26 pm | N/A N/A | OS Therapies Inc | OSTX | Search Theodore F. Director | 0 | $0 | 495,835 (Indirect) | View |